ClearSeq AML panel targets 20 genes that were identified in collaboration with Dr. Robert Ohgami and Dr. Daniel Arber at Stanford University to be frequently mutated in acute myeloid leukemia (AML). This panel is designed for full coverage of target regions with multiple amplicons covering each target for greater confidence in somatic variant calling. Combined with intuitive data analysis workflows in Agilent’s SureCall software, you can now achieve faster time to results using this quick and simple assay for profiling myeloid samples.Compatible with HaloPlex Target Enrichment System
貨號 | 產品 | 數量 | |
---|---|---|---|
G9913A | ClearSeq AML, ILM | 16 rxns | |
G9913B | ClearSeq AML, ILM | 96 rxns | |
G9914A | ClearSeq AML, ION | 16 rxns | |
G9914B | ClearSeq AML, ION | 96 rxns |